These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39121198)

  • 1. A New Genetic Signature of Lactate Metabolism-Associated Genes Predicting Clinically Distinctive Features and Tumor Microenvironment in Colorectal Cancer.
    Wang K; Lou Y; Tao Z
    Cancer Control; 2024; 31():10732748241272721. PubMed ID: 39121198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma.
    Li Y; Mo H; Wu S; Liu X; Tu K
    Front Cell Dev Biol; 2021; 9():801959. PubMed ID: 35047511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer.
    Huang A; Sun Z; Hong H; Yang Y; Chen J; Gao Z; Gu J
    J Transl Med; 2024 Jun; 22(1):587. PubMed ID: 38902737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.
    Shi R; Li H; Wei S; Yu Z; Zhang J; Zhang Q; Zhou T; Yao Y; Zhang Q; Zhang T; Wang H
    BMC Cancer; 2023 May; 23(1):491. PubMed ID: 37259038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a combined hypoxia and lactate metabolism prognostic signature in lung adenocarcinoma : Author.
    Sun J; Jiang R; Hou L; Wang L; Li M; Dong H; Dong N; Lin Y; Zhu Z; Zhang G; Zhang Y
    BMC Pulm Med; 2024 Jul; 24(1):323. PubMed ID: 38965505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer.
    Li L; Li Y; Lin J; Pang W
    Technol Cancer Res Treat; 2024; 23():15330338241277584. PubMed ID: 39155627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer.
    Zhu L; Lin Z; Wang K; Gu J; Chen X; Chen R; Wang L; Cheng X
    Front Endocrinol (Lausanne); 2024; 15():1372413. PubMed ID: 38529390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma.
    Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM
    World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
    Liu J; Yu F; Liu Z; Wang X; Li J
    Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer.
    Zhang Z; Fang T; Lv Y
    Front Genet; 2022; 13():934830. PubMed ID: 36171887
    [No Abstract]   [Full Text] [Related]  

  • 16. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma.
    Yang C; Huang S; Cao F; Zheng Y
    BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
    Wang H; Wang W; Wang Z; Li X
    Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study.
    Ping G; Tian Y; Zhou Z
    Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
    Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
    Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.